These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38188143)
1. The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer. Shan Y; Liu D; Li Y; Wu C; Ye Y PeerJ; 2024; 12():e16594. PubMed ID: 38188143 [TBL] [Abstract][Full Text] [Related]
2. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients. Shi H; Fang X; Li Y; Zhang Y Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160 [TBL] [Abstract][Full Text] [Related]
3. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors. Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker. Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119 [TBL] [Abstract][Full Text] [Related]
5. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells. Ji L; Tang Y; Pang X; Zhang Y Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma. Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674 [TBL] [Abstract][Full Text] [Related]
7. Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis. Zeng Y; Zhang J; Xu M; Chen F; Zi R; Yue J; Zhang Y; Chen N; Chin YE J Cancer; 2021; 12(19):5888-5894. PubMed ID: 34476002 [TBL] [Abstract][Full Text] [Related]
8. SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling. Wang W; Wang M; Du T; Hou Z; You S; Zhang S; Ji M; Xue N; Chen X Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108312 [TBL] [Abstract][Full Text] [Related]
9. SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma. Ning S; Ma S; Saleh AQ; Guo L; Zhao Z; Chen Y Gastroenterol Res Pract; 2018; 2018():4369253. PubMed ID: 30228815 [TBL] [Abstract][Full Text] [Related]
10. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma. Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169 [TBL] [Abstract][Full Text] [Related]
11. SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer. Jin M; Lee WK; You MH; Jang A; Cheng SY; Kim WG; Jeon MJ; Lee YM Endocr Connect; 2021 Jun; 10(6):630-636. PubMed ID: 34010151 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of SHMT2 enhances the sensitivity of gastric cancer cells to radiotherapy through the Wnt/β-catenin pathway. Mao Y; Zhang T Open Life Sci; 2022; 17(1):1249-1255. PubMed ID: 36213384 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis. Xu LP; Qiu HB; Yuan SQ; Chen YM; Zhou ZW; Chen YB J Cancer; 2020; 11(9):2708-2715. PubMed ID: 32201541 [No Abstract] [Full Text] [Related]
14. Exosome-mediated transfer of circ_0063526 enhances cisplatin resistance in gastric cancer cells via regulating miR-449a/SHMT2 axis. Yang G; Tan J; Guo J; Wu Z; Zhan Q Anticancer Drugs; 2022 Nov; 33(10):1047-1057. PubMed ID: 36206102 [TBL] [Abstract][Full Text] [Related]
15. Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism. Zhao M; Hou Y; Du YE; Yang L; Qin Y; Peng M; Liu S; Wan X; Qiao Y; Zeng H; Cui X; Teng Y; Liu M Cancer Lett; 2020 May; 478():8-21. PubMed ID: 32142918 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer. Wang H; Chong T; Li BY; Chen XS; Zhen WB Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813 [TBL] [Abstract][Full Text] [Related]
17. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression. Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G Can J Gastroenterol Hepatol; 2022; 2022():3758697. PubMed ID: 35211429 [TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer. Chu XD; Lin ZB; Huang T; Ding H; Zhang YR; Zhao Z; Huangfu SC; Qiu SH; Guo YG; Chu XL; Pan JH; Pan YL BMC Cancer; 2022 Mar; 22(1):250. PubMed ID: 35255858 [TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer. Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949 [TBL] [Abstract][Full Text] [Related]
20. Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade. Yin K Onco Targets Ther; 2015; 8():1069-74. PubMed ID: 25999742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]